People · Operator
Named in public records as an officer, director or promoter · active 2010–2022 · Pharmaceuticals, Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NovaBay Pharmaceuticals, Inc. | — | Pharmaceuticals | Series D+ | $218.1M | $913.2M | 2019 |
| Solta Medical Inc | — | Other Health Care | Series B | $47.5M | $564.9M | 2010 |
| Mawson Infrastructure Group Inc. | — | Other Technology | Series B | $40.3M | $4.4M | 2020 |
| OT Global, LLC | — | Other Health Care | Series A | $6.1M | $57.9M | 2018 |
| Orange Twist LLC | — | Other Health Care | Pre-Seed | $190K | $4.7M | 2020 |
Mark Sieczkarek at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Sieczkarek on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Clint Carnell | 3 | 4 |
| Jared Smith | 2 | 5 |
| Brittany Slater | 2 | 2 |
| Kenneth Kay | 2 | 2 |
| Jeffrey Seery | 2 | 2 |
| GREG MARTIN | 1 | 12 |
| Ron Mayron | 1 | 6 |
| ANDREW JONES | 1 | 6 |
| Eric Stang | 1 | 4 |
| Michael Hughes | 1 | 3 |
| David Holthe | 1 | 3 |
| Or Eisenberg | 1 | 2 |
| GAIL MADERIS | 1 | 2 |
| Paul E. Freiman | 1 | 2 |
| Joseph Zarzewsky | 1 | 2 |
| Charles Cashion | 1 | 2 |
| Paul Freiman | 1 | 2 |
| Gail J. Maderis | 1 | 2 |
| Cathy McCarthy | 1 | 2 |
| William Brodie | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.